Spine ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain byJosh SandbergJune 18, 2025
Biologics Spine BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease byTim AllenJune 13, 2025
Spine Top Stories Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System byTim AllenJune 3, 2025
Recon Regulatory Sports Medicine Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant byTim AllenMay 20, 2025
Biologics Spine Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data byTim AllenMay 13, 2025
Regulatory Lipogems Announces Enrollment of the Final Patient in ARISE FDA Clinical Trials for Knee Osteoarthritis byJosh SandbergMarch 5, 2025
Neuro Spine Mainstay Medical Announces Positive Results from the Landmark ReActiv8® RESTORE Clinical Trial byTim AllenJanuary 16, 2025
Spine Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc® 2-Level IDE clinical trial byJosh SandbergSeptember 25, 2024
Spine Top Stories Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain byJosh SandbergSeptember 24, 2024
Sports Medicine Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi byTim AllenSeptember 17, 2024
